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Introduction
The Locomotor Experience Applied Post-Stroke (LEAPS) 
trial compared 2 conceptually different rehabilitation inter-
ventions: (1) task-specific walking training on a treadmill 
with partial body-weight support coupled with overground 
walking delivered in a rehabilitation center either 2 (early 
locomotor training program [E-LTP]) or 6 months after 
stroke (late [L]-LTP) and (2) an impairment-based progres-
sive strength and balance exercise program delivered in the 
home 2 months after stroke (home exercise program 
[HEP]).1 The LEAPS participants were adults who at 2 
months poststroke still had not achieved unlimited commu-
nity ambulation (≥0.8 m/s walking speed) and thus could 
walk either only in the home or on a limited basis in the 
community.2
Deferral of treatment for one-half of the participants ran-
domized to LTP until 6 months poststroke (L-LTP group) 
provided the basis for this planned secondary analysis com-
paring the effects of E-LTP and HEP combined with usual 
care (UC) with UC alone at 6 months poststroke.3 HEP was 
originally conceptualized as a control intervention, one that 
would match LTP in dose, intensity, and goal-oriented 
focus, but because of the lack of an explicit walking compo-
nent, it was not expected to have an important impact on the 
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Abstract
Background. After inpatient stroke rehabilitation, many people still cannot participate in community activities because of limited 
walking ability. Objective. To compare the effectiveness of 2 conceptually different, early physical therapy (PT) interventions 
to usual care (UC) in improving walking 6 months after stroke. Methods. The Locomotor Experience Applied Post-Stroke 
(LEAPS) study was a single-blind, randomized controlled trial conducted in 408 adults with disabling hemiparetic stroke. 
Participants were stratified at baseline (2 months) by impairment in walking speed: severe (<0.4 m/s) or moderate (0.4 to 
<0.8 m/s). Between 2 and 6 months, they received either only UC (n = 143) or UC plus 36 therapist-provided sessions of 
either (1) walking training on a treadmill using body-weight support and practice overground at clinics (locomotor training 
program [LTP], n = 139) or (2) impairment-based strength and balance exercise at home (home exercise program [HEP], n 
= 126). Results. LTP participants were 18% more likely to transition to a higher functional walking level: severe to >0.4 m/s 
and moderate to >0.8 m/s than UC participants (95% confidence interval [CI] = 7%-29%), and HEP participants were 17% 
more likely to transition (95% CI = 5%-29%). Mean gain in walking speed in LTP participants was 0.13 m/s greater (95% CI 
= 0.09-0.18) and in HEP participants, 0.10 m/s greater (95% CI = 0.05-0.14) than in UC participants. Conclusions. Progressive 
PT, using either walking training on a treadmill and overground, conducted in a clinic, or strength and balance exercises 
conducted at home, was superior to UC in improving walking, regardless of severity of initial impairment.
Keywords
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level of functional walking ability. The amount and type of 
UC were not managed by LEAPS investigators. Thus, UC 
physical therapy (PT) was provided based on practice stan-
dards across our 6 regional sites.
This analysis addresses a clinically important question 
for practitioners and patients: are current practices of post-
acute PT as effective in improving the likelihood of func-
tional walking after stroke as the progressive interventions 
used in the LEAPS trial?4
Methods
Study Design
The LEAPS trial was a multicenter, single-blind random-
ized controlled trial, stratified by walking impairment 
level at 2 months after onset of stroke. We classified 
severe impairment as walking at <0.4 m/s and moderate 
impairment as walking at 0.4 to <0.8 m/s. Proportional 
randomization to protocol intervention groups (LTP, HEP) 
and UC was 7:6:7. Physical therapists conducting baseline 
and postintervention assessments were blinded as to the 
intervention group. The LEAPS protocol and primary out-
comes have been reported.1,3
Study Population and Screening
Participants were recruited from 6 inpatient rehabilitation 
sites in California and Florida. Inclusion criteria were age 
≥18 years, stroke within 45 days, residual paresis in the 
lower extremity, ability to walk 10 feet with no more than 
1-person assistance and follow a 3-step command, physi-
cian approval for participation, self-selected 10-m walking 
speed less than 0.8 m/s, and living in the community by the 
time of randomization. Exclusion criteria included depen-
dence in activities of daily living (ADL) prior to stroke, 
exercise contraindications, preexisting neurological disor-
ders, and inability to travel to the treatment site.1
Interventions
The LTP and HEP programs were controlled for exercise 
frequency (90 minute sessions, 3 times per week) and dura-
tion (12-16 weeks), for a total of 30 to 36 exercise sessions. 
LTP included stepping on a treadmill with partial body-
weight support for 20 to 30 minutes at 3.2 km/h (0.89 m/s or 
2.0 miles/h) with manual assistance as needed, followed by 
a progressive overground walking program sustained for 15 
minutes, provided in an outpatient facility by 2 physical 
therapists and a rehabilitation technician, as needed. HEP 
included progressive flexibility, range of motion, upper- 
and lower-extremity strength, coordination, and static and 
dynamic balance exercises provided by a physical therapist 
in the home. No specific walking activity was undertaken.
In addition to the LTP and HEP interventions, all partici-
pants were allowed to receive any prescribed usual and cus-
tomary care during this 6-month trial. Participants were 
instructed to submit a monthly calendar logging the date 
and duration of all UC PT sessions. LEAPS study personnel 
reviewed the logs with participants by phone, monthly.
Outcomes
The primary outcome measure in the present report was the 
proportion of participants who improved their functional 
level of walking at 6 months poststroke—the same outcome 
used for the 1-year poststroke analysis already reported.3 
Improved functional walking level at 6 months after stroke 
was defined as the ability to walk independently at a speed 
of 0.4 m/s or higher if entry speed was <0.4 m/s or at 0.8 
m/s if initial walking speed was 0.4 to <0.8 m/s.1,3,5 
Secondary walking outcomes included changes in 10-m 
walking speed,6 distance walked in 6 minutes,7 and number 
of steps taken per day measured with a step activity moni-
tor.8 Other outcome measures included the Fugl-Meyer 
assessment of lower-extremity motor impairment (FM-LE), 
total sensory and motor FM scores,9,10 the Berg Balance 
Scale (BBS),11 the Activities-Specific Balance Confidence 
(ABC) Scale,12 the ADL/Instrumental ADL (IADL) Scale, 
physical mobility and participation domains of the Stroke 
Impact Scale,13 and the modified Rankin Scale as a measure 
of overall disability.14
Adverse Events
Death, life-threatening adverse events (stroke, myocardial 
infarction, and fracture caused by a fall), rehospitalization, 
and new disability or incapacity that led to more than 48 
hours of limitation in ADL were considered serious adverse 
events.1 Minor adverse events included a fall with no frac-
ture, dyspnea during treatment, an open sore or blister, cuts, 
muscle soreness or pain that persisted for more than 48 
hours, dizziness/faintness, diaphoresis, hypertension or 
hypotension during exercise that halted the intervention for 
the day, and deep venous thrombosis.1
Statistical Analysis
To examine the effectiveness of LTP and HEP interventions 
relative to UC, we conducted an intention-to-treat logistic 
regression analysis with successful recovery of walking at 6 
months poststroke as the dependent variable. Odds ratios for 
the primary outcome were calculated relative to UC, adjust-
ing for baseline walking impairment category (severe, mod-
erate), clinical site, stroke type, side of hemiparesis, presence 
of depression, and age. The planned imputation method for 
missing data reduced to the last-observation-carried-forward 
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approach because none of the dropped out participants had a 
related adverse event.1,3
Paired t tests were used to compare within-group 
improvements, and analysis of variance (ANOVA) was 
used to assess differences across the 3 groups for the sec-
ondary outcome measures, followed by pairwise compari-
sons with Bonferroni adjustment for multiple testing. The 
Kruskal-Wallis procedure was used to compare the groups 
on the number of steps taken in the community. To deter-
mine the effect of number of UC visits on walking speed 
change, a separate linear regression analysis was conducted. 
All statistical analyses were performed using SAS software, 
version 9.1 (SAS Inst Inc, Cary, North Carolina).
All tests for statistical significance were 2-tailed. The 
threshold α value was set at .05.
Results
Baseline Characteristics
Of 5289 stroke admissions from April 2006 through June 
2009, 4909 patients were screened for study eligibility, and 
3137 were excluded (Figure 1). At the second screening 2 
months after stroke onset, 1364 patients were excluded. The 
most common reasons for exclusion were the presence of 
one or more major coexisting medical conditions, absence 
of residual paresis in the leg on the side of the body affected 
by stroke, absence of a primary diagnosis of stroke, no 
expectation of home discharge, a self-selected walking 
speed greater than 0.8 m/s, and refusal to provide informed 
consent. Also, 19 persons did not pass the exercise tolerance 
test before randomization. Of the 408 participants included 
in the intention-to-treat analysis, 139 were assigned to LTP 
(delivered at 2 months poststroke), 143 to UC (UC only at 2 
months poststroke, and then LTP at 6 months), and 126 to 
exercise delivered in the home at 2 months poststroke. 
Participants who completed the study were 62.0 ± 12.7 
years old; 54.9% were men. and 22.1% were African 
American (Table 1). Also, 71% had ischemic stroke, and 
99.5% had modified Rankin scores of 2 to 4 (slight disabil-
ity to moderately severe disability). Participants were ran-
domized 63.8 ± 8.5 days poststroke; 53.4% walked at <0.4 
m/s, and 46.6% walked at 0.4 to 0.79 m/s. Stratified ran-
domization by site resulted in no significant site differences 
in the percentage of participants receiving the 3 treatments. 
However, randomization was not done by therapist, so indi-
vidual therapists provided differentce mixes of the 3 proto-
col treatments. Major comorbidities were hypertension, 
diabetes, and cardiovascular disease. More than a third had 
arthritis or musculoskeletal complaints. The baseline char-
acteristics of those who were lost to follow-up at 6 months 
are presented in Table 1. The distribution of participants 
randomized to each intervention group and relative to the 
number of therapists conducting the interventions at each 
site is reported in Table 2.
Interventions
The percentage of participants who did not complete the 
intervention at 6 months was 13% for LTP and 3% for HEP 
(P < .001). The LTP group completed an average of 33 ± 7 
sessions and the HEP group 36 ± 3 sessions. Session dura-
tion for LTP was 83 ± 6 minutes and for HEP 76 ± 10 min-
utes. LTP progression from the first 3 to last 3 sessions was 
evident for treadmill walking time (mean ± SD = 14 ± 5 to 
23 ± 5 minutes), treadmill speed (1.7 ± 1.7 to 2.0 ± 0.4 
miles/h), percentage body-weight support (31.0 ± 6.1 to 
11.8 ± 8.5), and overground training level of difficulty (56% 
transitioned to a higher level). For the HEP group, the num-
ber of repetitions, resistance, and level of difficulty 
increased for upper- and lower-extremity flexor and exten-
sor exercises, as did sitting and standing balance activities 
across the intervention period.
The amount of usual and customary rehabilitation after 
acute hospitalization was highly variable within each 
group. The median number of UC PT visits was 7 for LTP 
(range, 0-56), 13 for HEP (range, 0-86), and 11 for UC only 
(range, 0-69). Of 408 participants, 21.6% did not receive 
any PT after their inpatient rehabilitation hospitalization. 
The proportion that received no PT outside the study was 
higher for the LTP group (30.9%) than HEP (15.9%) and 
UC groups (17.5%). The average length of time for UC 
visits was 53 ± 14 minutes for LTP, 54.0 ± 11 for HEP, and 
53 ± 14 for UC only.
Outcomes
At 6 months, 50.4% of LTP, 49.2% of HEP, and 32.2% of 
UC participants had improved to a higher functional 
walking level (Table 3). The difference between LTP and 
UC was 18% (95% confidence interval [CI] = 7%-29%) 
and between HEP and UC, 17% (95% CI = 5%-29%). The 
adjusted odds ratio for achieving a higher functional 
walking level with LTP compared with UC was 1.94 (95% 
CI = 1.18-3.21; P = .010) and for HEP compared with 
UC, 2.04 (95% CI = 1.22-3.42; P = .007). There was no 
difference in gains between LTP and HEP, and severity of 
initial walking impairment had no impact on gains. Site 
of treatment had no impact on gains either.
From baseline, all 3 groups improved their walking 
speed (P < .0001; Figure 2), 6-minute walk distance, and 
number of community steps taken per day (Table 4). 
However, LTP and HEP groups had greater walking speed 
increases (LTP, 0.25 ± 0.21 m/s; HEP, 0.23 ± 0.20 m/s) than 
the UC group (UC, 0.13 ± 0.14 m/s; P < .0001), correspond-
ing to medium effect sizes of 0.72 and 0.56, respectively 
(Table 3). The difference in walking speed gain between 
LTP and UC was 0.13 m/s (95% CI = 0.09-0.18) and 
between HEP and UC, 0.10 m/s (95% CI = 0.05-0.14).
All 3 groups also significantly improved (P < .0001) 
from baseline in ADL/IADL, physical mobility and social 
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Figure 1. Consort diagram.
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Table 1. Baseline Characteristics by Intervention Group for All Participants and for Those Who Were Lost to Follow-up.
All Participants Lost to Follow-up
 All LTP HEP UC All LTP HEP UC
Item (n = 408) (n = 139) (n = 126) (n = 143) (n = 24) (n = 11) (n = 6) (n = 7)
Male gender, n (%) 224 85 (61.2) 65 (51.6) 74 (51.7) 12 5 (45.5) 3 (50.0) 4 (57.1)
Age at stroke onset,  
y, mean ± SD
62.0 ± 12.7 60.1 ± 12.3 62.6 ± 13.3 63.3 ± 12.5 65.5 ± 12.7 65.1 ± 13.1 57.8 ± 6.7 72.6 ± 13.5
Race, n (%)  
 Asian 54 19 (13.7) 15 (11.9) 20 (14.0) 6 1 (9.1) 2 (33.3) 3 (42.9)
 Black or African  
  American
90 32 (23.0) 24 (19.0) 34 (23.8) 8 4 (36.4) 3 (50.0) 1 (14.3)
 White 236 81 (58.3) 78 (61.9) 77 (53.8) 10 6 (54.5) 1 (16.7) 3 (42.9)
 Other 28 7 (5.0) 9 (7.1) 12 (8.4)  
Ethnicity, n (%)
 Hispanic or Latino 63 26 (18.7) 22 (17.5) 15 (10.5) 4 2 (18.2) 1 (16.7) 1 (14.3)
 Non-Hispanic or  
  Latino
345 113 (81.3) 104 (82.5) 128 (89.5) 20 9 (81.8) 5 (83.3) 6 (85.7)
Education, n (%)
 <High school 92 35 (25.2) 28 (22.2) 29 (20.3) 8 1 (9.1) 4 (66.7) 3 (42.9)
 High school, GED 112 38 (27.3) 37 (29.4) 37 (25.9) 7 3 (27.3) 1 (16.7) 3 (42.9)
 >High school 204 66 (47.5) 61 (48.4) 77 (53.8) 9 7 (63.6) 1 (16.7) 1 (14.3)
Stroke characteristics
 Time between  
  stroke and  
  randomization,  
  d, mean ± SD
63.8 ± 8.5 64.1 ± 8.3 62.9 ± 8.0 64.2 ± 9.0 64.7 ± 7.3 64.9 ± 9.4 64.3 ± 5.3 64.6 ± 5.7
 Left hemiparesis,  
  n (%)
182 63 (45.3) 61 (48.4) 58 (40.6) 12 5 (45.5) 3 (50.0) 4 (57.1)
 Right hemiparesis,  
  n (%)
226 76 (54.7) 65 (51.6) 85 (59.4) 12 6 (54.5) 3 (50.0) 3 (42.9)
Stroke type based on CT/MRI, n (%)
 Large vessel 162 55 (39.6) 47 (37.3) 60 (42.0) 3 2 (18.2) 1 (14.3)
 Lacune 128 40 (28.8) 43 (34.1) 45 (31.5) 8 3 (27.3) 2 (33.3) 3 (42.9)
 Hemorrhage 70 27 (19.4) 21 (16.7) 22 (15.4) 4 1 (9.1) 2 (33.3) 1 (14.3)
 Undefined 48 17 (12.2) 15 (11.9) 16 (11.2) 9 5 (45.5) 2 (33.3) 2 (28.6)
Stroke severity (Modified Rankin Scale), n (%)
 Rankin 0-1 2 2 (1.4)  
 Rankin 2 54 12 (8.6) 21 (16.7) 21 (14.7) 1 1 (16.7)  
 Rankin 3 172 66 (47.5) 49 (38.9) 57 (39.9) 13 8 (72.7) 2 (33.3) 3 (42.9)
 Rankin 4 180 61 (43.9) 56 (44.4) 63 (44.1) 10 3 (27.3) 3 (50.0) 4 (57.1)
Comorbidities, n (%)
 Cardiovascular 109 36 (25.9) 37 (29.4) 36 (25.5) 5 2 (18.2) 3 (50.0)  
 Hypertension 331 116 (83.5) 104 (82.5) 111 (78.7) 20 9 (81.8) 5 (83.3) 6 (85.7)
  Peripheral vascular  
  disease
37 12 (8.6) 13 (10.3) 12 (8.5) 4 1 (9.1) 2 (33.3) 1 (14.3)
 COPD 26 5 (3.6) 7 (5.6) 14 (9.9) 2 1 (9.1) 1 (14.3)
 Arthritis/Other 146 47 (33.8) 47 (37.3) 52 (36.9) 11 7 (63.6) 1 (16.7) 3 (42.9)
 Diabetes 141 47 (33.8) 43 (34.1) 51 (36.2) 12 4 (36.4) 4 (66.7) 4 (57.1)
Depression (PHQ-9 ≥ 
10), n (%)
67 20 (14.4) 19 (15.1) 28 (19.6) 4 1 (9.1) 2 (33.3) 1 (14.3)
MMSE (range, = 0-30), 
mean ± SD
26.1 ± 3.5 26.0 ± 3.2 26.0 ± 3.6 26.2 ± 3.7 26.1 ± 3.6 27.3 ± 3.0 25.7 ± 3.3 24.7 ± 4.6
(continued)
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Table 2. Number of Participants and Therapists by Study Site.
Group
Brooks Rehabilitation 
Hospital, Jacksonville, 
FL
University of Southern 
California Physical  
Therapy Associates,  
Los Angeles, CA
Florida Hospital, 
Orlando, FL
Long Beach 
Memorial Hospital, 
Long Beach, CA
Sharp Regional 
Hospital,  
San Diego, CA All
LTP 33 33 23 30 20 139
HEP 29 26 22 30 19 126
UC 34 30 22 33 24 143
Total 96 89 67 93 63 408
Number of therapists 7 7 4 5 3 26
Abbreviations: LTP, locomotor training program; HEP, home exercise program; UC, usual care.
Table 3. Number of Patients (%) by Intervention Group for Dichotomous Outcomes, Serious Adverse Events, and Multiple Falls.a
Outcomes
No. (%) Difference (95% CI) Between Groups
LTP (n = 139) HEP (n = 126) UC (n = 143) LTP − UC HEP − UC LTP − HEP
Transitioned by  
  6 months
70 (50.4) 62 (49.2) 46 (32.2) 0.18 (0.07, 0.29) 0.17 (0.05, 0.29) 0.01 (−0.11, 0.13)
Modified Rankin  
  Scale, improved
69 (49.6) 62 (49.2) 57 (39.9) 0.10 (−0.02, 0.21) 0.09 (−0.03, 0.21) 0 (−0.12, 0.12)
Serious adverse  
  event
29 (20.9) 23 (18.3) 29 (20.3) 0.01 (−0.09, 0.10) −0.02 (−0.11, 0.07) 0.03 (−0.07, 0.12)
 Sustained  
  hospitalization
28 (20.1) 19 (15.1) 28 (19.6) 0.01 (−0.09, 0.10) −0.05 (−0.14, 0.05) 0.05 (−0.04, 0.14)
Multiple falls
  Participants with 
severe walking 
impairment
22 (29) 16 (24) 13 (17) 0.12 (−0.01, 0.26) 0.07 (−0.06, 0.21) 0.05 (−0.10, 0.20)
  Participants with 
moderate walking 
impairment
10 (16) 10 (17) 6 (9) 0.07 (−0.05, 0.18) 0.08 (−0.04, 0.19) −0.01 (−0.14, 0.12)
 All participants 32 (23.0) 26 (20.6) 19 (13.3) 0.10 (0.01, 0.19) 0.07 (−0.02, 0.16) 0.02 (−0.08, 0.12)
Abbreviations: LTP, locomotor training program; HEP, home exercise program; UC, usual care; CI, confidence interval.
a Statistically significant differences are in bold.
All Participants Lost to Follow-up
 All LTP HEP UC All LTP HEP UC
Item (n = 408) (n = 139) (n = 126) (n = 143) (n = 24) (n = 11) (n = 6) (n = 7)
Walking disability, n (%)
 Severe (<0.4 m/s) 218 75 (54.0) 66 (52.4) 77 (53.8) 14 4 (36.4) 5 (83.3) 5 (71.4)
 Moderate  
  (0.4-0.8 m/s)
190 64 (46.0) 60 (47.6) 66 (46.2) 10 7 (63.6) 1 (16.7) 2 (28.6)
Exercise tolerance test
 Exercise duration  
  (minutes),  
  mean ± SD
5.9 ± 2.2 6.1 ± 2.4 5.9 ± 2.0 5.8 ± 2.1 5.6 ± 1.7 6.1 ± 2.4 5.2 ± 0.6 5.2 ± 0.9
 Borg Exertion Scale  
  (range = 6-20),  
  mean ± SD
16.1 ± 3.7 16.3 ± 3.4 15.9 ± 4.6 16.2 ± 3.2 16.5 ± 2.5 17.7 ± 2.1 15.8 ± 2.5 15.1 ± 2.5
Abbreviations: LTP, locomotor training program; HEP, home exercise program; UC, usual care; SD, standard deviation; CT, computed tomography; 
MRI, magnetic resonance imaging; COPD, chronic obstructive pulmonary disease; PHQ-9, 9-item depression scale of the Patient Health Questionnaire; 
MMSE, Minination Mental State Examination.
Table 1. (continued)
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Figure 2. Comparison of mean walking speed for the 
locomotor training program (LTP), home exercise program 
(HEP), and usual care (UC) groups at 2 months (2mo) and 
6 months (6mo) poststroke; in addition, LTP and HEP mean 
walking speeds after 30 to 36 sessions of intervention (Post) 
were plotted.
participation, motor recovery (FM), balance score (BBS), 
balance confidence (ABC Scale), and modified Rankin 
score (Table 4). With Bonferroni adjustment for multiple 
testing, the LTP and HEP groups improved more than the 
UC group in BBS score, ABC Scale score, and physical 
mobility (P < .0014). In addition, there were trends toward 
more improvement in the LTP and HEP groups, relative to 
the UC group, in community steps taken, ADL/IADL, 
social participation, motor recovery (FM-LE), and modified 
Rankin scale (Table 4).
UC Postacute Rehabilitation
The number of UC PT visits provided in addition to the 30 
to 36 visits received by the LTP and HEP groups was not 
associated with changes in walking speed (P = .287). 
However, within the UC-only group (n = 139), a positive 
association was observed between number of PT visits 
(median = 11, range = 0-69) and walking speed change (P = 
.049), adjusting for age and baseline walking speed but not 
for multiple comparisons.
Adverse Events
There were no between-group differences in total serious 
adverse events incurred between randomization and 6 
months poststroke (Table 3, P = .86). In all, 41% of partici-
pants reported at least 1 fall (1.7% had an injurious fall), but 
no significant differences were found across groups. 
Overall, 19% experienced multiple falls (LTP, 23%; HEP, 
21%; and UC, 13%; P = .09). The LTP group had a greater 
risk of multiple falls than the UC group. Minor adverse 
events were reported by 21% of participants, with no sig-
nificant differences between LTP and HEP, except that the 
HEP group reported fewer incidents of dizziness/faintness 
during exercise (0%) than the LTP group (7.9%, P = .001).
Discussion
This study demonstrates the benefits of physical rehabilita-
tion and the potential for gains in functional walking 
between 2 and 6 months after stroke in participants who had 
been discharged from inpatient rehabilitation. Of particular 
importance is that the benefit occurred during the period in 
which rehabilitation is customarily offered to patients with 
hemiparesis, and costs are usually covered by Medicare. 
Standardized PT interventions that included either a pro-
gressive task-specific LTP provided in an outpatient clinic 
or a progressive strength and balance exercise program pro-
vided in the home, both in substantial doses, were more 
effective in improving walking ability than postacute stroke 
physical rehabilitation provided according to current com-
munity practices in California and Florida. HEP and LTP 
initiated at 2 months after stroke produced equivalent out-
comes at the 6-month assessment, as they did at 1 year.3
The change in walking speed at 6 months poststroke 
achieved by the UC group (0.13 m/s) was only 52% of that 
achieved by the LTP group (0.25 m/s) and 57% of that 
achieved by the HEP group (0.23 m/s), whether initial walk-
ing impairment was severe or moderate. The effect sizes for 
LTP and HEP relative to UC were 0.72 and 0.56, respec-
tively, which rank as medium. The changes in walking 
speed for the LTP and HEP groups exceeded the minimal 
clinically important difference for walking speed for 
patients poststroke during the subacute period (0.16 m/s)15 
and minimal clinically important differences (0.175-0.19 
m/s)16 anchored to changes in Modified Rankin score, 
patient-perceived change in walking ability, and physical 
therapist–perceived change in walking ability. In compari-
son, the walking speed change for the UC group did not 
reach the established minimal clinically important differ-
ences. Our findings of significantly greater improvement in 
secondary measures of physical mobility, balance (BBS), 
and balance confidence (ABC) by the LTP and HEP groups 
compared with the UC group are consistent with known 
correlations of walking speed with other measures of 
impairment, activity, and participation.5
The differences in the results of the 2 interventions tested 
by LEAPS and those of UC were clinically important. In the 
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LTP group, 18% more patients than in the UC group 
achieved a transition to a higher level of functional walking 
ability. The corresponding value in the HEP group was 
17%. Transitioning to a higher level of walking ability as a 
result of increased walking speed poststroke is associated 
with improvements in mobility and participation. Household 
ambulators (<0.4 m/s walking speed) poststroke who transi-
tion to limited community (≥0.4 m/s and <0.8 m/s) or full 
ambulatory status (≥0.8 m/s) demonstrate significantly 
greater changes in mobility and participation, based on the 
Stroke Impact Scale, compared with stroke survivors who 
do not transition.5 Similarly, those who transition from lim-
ited community to unlimited ambulatory status also demon-
strate significant changes in participation in contrast to 
persons who do not transition.5 In the LEAPS trial, the 
number needed to treat to yield 1 additional patient transi-
tioning to a higher functional walking level was 6. Thus, a 
relatively small number of patients must be treated to yield 
1 additional success when structured, progressive forms of 
therapy are provided in adequate dose. LEAPS is the largest 
clinical trial to test conceptually based, well-defined inter-
ventions for walking after disabling stroke, so the findings 
are likely to generalize to people with similar hemiparesis 
after stroke who are discharged home after inpatient reha-
bilitation but still are disabled in walking.
Usual Care
The number and duration of UC therapy sessions were care-
fully monitored, but the content was not. Other studies, 
however, have described UC after postacute rehabilitation 
hospitalization, whether delivered in the home or in the out-
patient clinic.17,18 Duncan et al17 observed that the number 
of PT visits averaged 8.7 (±5.3), and average visit duration 
was 45.6 (±12.2) minutes. They found an even greater per-
centage of individuals who did not receive any UC (46%) 
than we did (21.6%). A survey by the Center for Disease 
Control of 21 states and the District of Columbia (2005) 
indicated that 60.3% of stroke patients receive no outpatient 
rehabilitation therapy and that this proportion was higher 
than expected if clinical practice guidelines on rehabilita-
tion had been followed.19 Duncan et al17 found that therapy 
was focused on improving strength in 50% of patients, 
mobility in 50%, balance in 48%, range of motion in 21%, 
ADL/independent ADL in 14%, and endurance in 8%. 
There was considerable variability in the type of exercise 
used. Exercise directed toward improving endurance and 
strength was progressed in only 13% to 28% of patients. 
Lang et al18 reported that outpatient treatment sessions aver-
aged 36 minutes, and the number of repetitions of task prac-
tice was relatively small (eg, lower-extremity active 
exercise included 33 repetitions, and transfers were repeated 
10 times). High variability across patients in the number of 
repetitions and activity type was also observed. Lang et al18 
suggested that with an average of 7 different activities 
practiced within each outpatient session, the opportunity for 
more intense practice may have been limited. Thus, UC-only 
PT, with a median of 11 visits and average duration of 52.5 
(±13.5) minutes, may not have provided a high enough dose 
of practice with a concentrated emphasis on progression of 
skill training and neuromuscular challenge to achieve maxi-
mal gains in mobility.
For both LEAPS interventions, even with their very dif-
ferent training techniques (ie, task-specific training vs 
impairment-based training), participant baseline ability was 
used to set goals, and participant ability was challenged 
during each training session. Therapists delivering both 
HEP and LTP were trained to rigorously advance progres-
sion in every session, and participants were engaged in set-
ting goals for practice. Feedback about mobility and 
exercise during PT has a positive effect on subsequent per-
formance.20 For LTP, progression occurred in the form of 
increased body weight load, stepping time, treadmill speed, 
and independence on the treadmill and in overground walk-
ing. During HEP, progression was achieved by increasing 
the number of repetitions, resistance, and task and balance 
difficulty. Other than pointing to the effects of greater struc-
tured practice, our data do not enable us to measure how 
such factors may have been responsible for the greater effi-
cacy of HEP and LTP relative to UC.
With the number of UC PT visits (median 11 visits, 
range 0-69) observed for the UC-only group, improvements 
in walking speed did not reach those achieved by the LTP 
and HEP groups. A greater number of UC visits in the 
UC-only group was weakly but significantly associated 
with improvement in walking speed. However, the number 
of UC PT visits received in addition to LTP and HEP ses-
sions did not seem to affect the final walking speed of these 
groups. The significant advantage of LTP and HEP in 
achieving meaningful changes in walking compared with 
only UC may be attributable to standardization, higher 
dose, the rigor of progression and challenge, and the spe-
cific features of these therapies, that is, task-specific walk-
ing training and impairment-based exercise.
Our results might lead to the inference that HEP and 
LTP were superior to UC simply by virtue of the greater 
quantity and intensity of therapy received. However, as 
noted, there was but a weak relationship between number 
of UC sessions and gains in walking speed. Furthermore, 
because HEP and LTP achieved similar results, it does not 
mean that they did so by the same mechanisms. It is pos-
sible that the same neuroplastic mechanisms can be 
engaged by the 2 different treatments or the 2 treatments 
engage different but complementary mechanisms. Despite 
possible differential engagement at the individual partici-
pant level, at the population level, the 2 treatments appear 
to be equivalent. In addition, the conduct of HEP in the 
home may have enhanced its efficacy. Learning research 
provides much evidence that retention is dependent on the 
extent of commonality between circumstances at training 
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and circumstances at time of retrieval.21,22 Our trial did not 
address the issue of whether task-specific training has less 
conceptual validity than generally thought or whether 
training on a treadmill with body-weight support is less 
task specific than usually considered.
A higher risk of multiple falls in the LTP group than in 
the UC group may hypothetically be attributed to multiple 
factors (eg, medications, vision, urinary incontinence, bal-
ance, and home environment).23 Because mobility skills 
were challenged during training, the LTP group may have 
taken greater risks during ambulation or transfers in the 
home and community than the HEP or UC groups.24 On the 
other hand, the HEP group received home-based therapy, 
and treatments (eg, strength and balance training) were 
practiced where most falls occur—in the home. This may 
have had an effect in reducing falls risk.
The 1-year outcomes of the LEAPS trial determined that 
the task-specific locomotor training was not superior to the 
impairment-based exercise program.3 However, the com-
parison at 6 months poststroke of LTP and HEP with UC 
determined that both interventions were superior to UC in 
terms of the proportion of participants that transitioned to a 
higher functional level of walking. Just as for the 1-year 
outcomes, 50.4% of those who received LTP and 49.2% of 
those who received HEP successfully transitioned to a 
higher functional level of walking at 6 months. Although 
this success rate is significant and clinically meaningful for 
LTP and HEP groups, nearly half of our participants (49.6% 
in the LTP and 50.8% in the HEP group) did not achieve a 
successful outcome after 30 to 36 sessions. However, 68% 
of the UC group did not achieve a successful outcome. 
Further studies are needed to evaluate the conceptual bases 
and mechanisms of effect for the interventions (eg, neuro-
muscular benefit, home-based vs clinic-based therapy, 
patient preference), to examine the appropriate therapy 
dose, and to combine or augment these interventions25 to 
increase the proportion of individuals who transition to a 
higher level of functional walking ability.
Limitations
The characterization of UC was limited to the number of PT 
visits and the time spent in a PT session. No information 
was collected on the goals that were addressed during the 
PT sessions (eg, transfers, bed mobility, and ambulation) or 
the particular interventions that were used (eg, neuromuscu-
lar reeducation, balance training, and gait training). Other 
forms of physical rehabilitation, such as occupational ther-
apy, may also have been provided and may have affected 
functional gains. The reason for the modest number of UC 
visits received by each patient is not known, but it could 
reflect acceptance of functional status, prescribing prac-
tices, accessibility to care, and psychosocial reasons.
Summary
Standardized, progressive, goal-oriented, and individual-
ized HEP and LTP programs delivered with substantial fre-
quency, intensity, and duration were more effective in 
improving functional walking ability than PT provided 
according to current usual practices. Improvements in walk-
ing speed in the LTP and HEP groups were twice those of 
UC and exceeded thresholds for minimal clinically impor-
tant differences. These findings suggest that more struc-
tured and progressive PT interventions, using task-specific 
or impairment-based training, have the potential for better 
rehabilitation outcomes for persons disabled after stroke.
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